Hashem El-Serag
Baylor College of Medicine
Appearances
DateMay 7, 2023Attendees should attend this session to learn about practical examples of successful quality improvement projects for integration into their day to day work lives. This session will also provide guidance on how to develop a quality improvement project…Presenter
Speakers
- DateMay 21, 2024BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
Presenter
Speakers
University of MichiganMayo Foundation for Medical Education and ResearchBaylor College of MedicineBaylor University Medical CenterMichael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterUniversity of Texas Southwestern Medical Center - DateMay 21, 2024BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
Presenter
Baylor College of MedicineSpeakers
Michael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterBaylor University Medical Center - DateMay 18, 2024BACKGROUND: Patients with MASLD and diabetes have an increased risk of cirrhosis and hepatocellular cancer (HCC). Recent studies show that glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide, are effective in improving liver inflammation in MASLD…
Presenter
Michael E. DeBakey VAMCSpeakers
The Perelman School of Medicine at the University of PennsylvaniaBaylor College of Medicine 
DateMay 4, 2025Endoscopic screening for gastric preneoplasia and neoplastic lesions remains an under-recognized area in GI practice and continues to generate a great deal of controvery…Moderators
Baylor College of MedicineErasmus University Medical Center
